what's the difference in semaglutide and tirzepatide vs Semaglutide or tirzepatide - which

Continued research led to the first GLP-1 drugs approved for weight loss in people with obesity or overweight: liraglutide or Saxenda in 2014, semaglutide as Wagovy in 2021 and tirzepatide as Zepbound in 2023

Studies in sleep medicine show that changes in hormones and metabolism can have an effect on sleep by affecting stress pathways instead of disrupting the structure of sleep

Common side effects include gastrointestinal issues, which lead to about 10% of patients discontinuing use, as well as risks like hypotension, pancreatitis, and the progression of diabetic retinopathy

Anticipating Results from Semaglutide Treatment Begin your semaglutide treatment with an initial low dose, gradually elevated to suit your tolerance and weight loss progress